MedPath

AMERICAN REGENT, INC.

AMERICAN REGENT, INC. logo
🇺🇸United States
Ownership
Subsidiary
Established
1967-01-01
Employees
501
Market Cap
-
Website
http://www.americanregent.com

Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients

Phase 3
Completed
Conditions
Postpartum Anemia
Interventions
Drug: Ferric Carboxymaltose (FCM)
Drug: Ferrous Sulfate tablets
First Posted Date
2006-07-20
Last Posted Date
2018-02-20
Lead Sponsor
American Regent, Inc.
Target Recruit Count
291
Registration Number
NCT00354484
Locations
🇺🇸

Luitpold Pharmaceuticals, Norristown, Pennsylvania, United States

Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

Phase 3
Completed
Conditions
Anemia
Interventions
Drug: Ferric Carboxymaltose (FCM)
First Posted Date
2006-04-24
Last Posted Date
2018-02-20
Lead Sponsor
American Regent, Inc.
Target Recruit Count
145
Registration Number
NCT00317226
Locations
🇺🇸

Luitpold Pharmaceuticals Inc., Norristown, Pennsylvania, United States

VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

Phase 3
Completed
Conditions
Anemia
Interventions
Drug: Ferrous Sulfate tablets
Drug: Ferric Carboxymaltose (FCM)
First Posted Date
2006-04-24
Last Posted Date
2018-02-20
Lead Sponsor
American Regent, Inc.
Target Recruit Count
255
Registration Number
NCT00317239
Locations
🇺🇸

Luitpold Pharmaceuticals, Norristown, Pennsylvania, United States

Taxoprexin Treatment for Advanced Skin Melanoma

Phase 2
Completed
Conditions
Metastatic Melanoma
First Posted Date
2005-11-07
Last Posted Date
2018-01-24
Lead Sponsor
American Regent, Inc.
Target Recruit Count
30
Registration Number
NCT00249262

Taxoprexin® Treatment for Advanced Eye Melanoma

Phase 2
Completed
Conditions
Metastatic Melanoma
First Posted Date
2005-10-27
Last Posted Date
2018-01-24
Lead Sponsor
American Regent, Inc.
Target Recruit Count
30
Registration Number
NCT00244816
Locations
🇺🇸

MD Anderson Cancer Center, Houston, Texas, United States

Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer

Phase 3
Completed
Conditions
Non-Small Cell Lung Cancer
Interventions
Drug: Taxoprexin
First Posted Date
2005-10-25
Last Posted Date
2018-01-26
Lead Sponsor
American Regent, Inc.
Target Recruit Count
519
Registration Number
NCT00243867
Locations
🇺🇸

US Oncology, Dallas, Texas, United States

Pharmacokinetic Study of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin

Phase 4
Completed
Conditions
Anemia
First Posted Date
2005-10-17
Last Posted Date
2018-01-24
Lead Sponsor
American Regent, Inc.
Target Recruit Count
8
Registration Number
NCT00239616

Safety and Efficacy of Iron Sucrose in Children

Phase 4
Completed
Conditions
Chronic Kidney Disease
Anemia
Interventions
First Posted Date
2005-10-17
Last Posted Date
2021-11-17
Lead Sponsor
American Regent, Inc.
Target Recruit Count
141
Registration Number
NCT00239642
Locations
🇺🇸

Luitpold Pharmaceutials, Norristown, Pennsylvania, United States

Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis

First Posted Date
2005-10-12
Last Posted Date
2021-05-19
Lead Sponsor
American Regent, Inc.
Target Recruit Count
121
Registration Number
NCT00236938

Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia

Phase 3
Completed
Conditions
Anemia
Interventions
First Posted Date
2005-10-12
Last Posted Date
2020-10-06
Lead Sponsor
American Regent, Inc.
Target Recruit Count
182
Registration Number
NCT00236977
Locations
🇺🇸

Luitpold Pharmaceuticals, Valley Forge, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath